Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
PLoS One ; 19(7): e0307641, 2024.
Article in English | MEDLINE | ID: mdl-39052597

ABSTRACT

Investments in renewable energy sources are increasing in several countries, especially in wind energy, as a response to global climate change caused by the burning of fossil fuels for electricity generation. Thus, it is important to evaluate the Regional Climate Models that simulate wind speed and wind power density in promising areas for this type of energy generation with the least uncertainty in recent past, which is essential for the implementation of wind farms. Therefore, this research aims to calculate the wind power density from Regional Climate Models in areas at Northeast of Brazil from 1986 to 2005. Initially, the ECMWF-ERA5 reanalysis data was validated against observed data obtained from Xavier. The results were satisfactory, showing a strong correlation in areas of Ceará and Rio Grande do Norte (except during the SON season), and some differences in relation to the wind intensity registered by observed data, particularly during the JJA season. Then, the Regional Climate Models RegCM4.7, RCA4 and Remo2009 were validated against the ECMWF-ERA5 reanalysis data, with all models successfully representing the wind speed pattern, especially from December to May. Four specific areas in Northeast of Brazil were selected for further study. In these areas, the RCMs simulations were evaluated to identify the RCM with the best statistical indices and consequently the lowest associated uncertainty for each area. The selected RCMs were: RegCM4.7_HadGEM2 (northern coastal of Ceará and northern coastal of Rio Grande do Norte) and RCA4_Miroc (Borborema and Central Bahia). Finally, the wind power density was calculated from the selected RCM for each area. The northern regions of Rio Grande do Norte and Ceará exhibited the highest wind power density.


Subject(s)
Wind , Brazil , Climate Models , Renewable Energy , Climate Change , Seasons
2.
Plast Reconstr Surg Glob Open ; 2(6): e168, 2014 Jun.
Article in English | MEDLINE | ID: mdl-25289361

ABSTRACT

BACKGROUND: Soccer is the most popular sport in Brazil and a high incidence of related trauma is reported. Maxillofacial trauma can be quite common, sometimes requiring prolonged hospitalization and invasive procedures. To characterize soccer-related facial fractures needing surgery in 2 major Brazilian Centers. METHODS: A retrospective review of trauma medical records from the Plastic Surgery Divisions at the Universidade Federal de São Paulo-Escola Paulista de Medicina and the Hospital das Clinicas-Universidade de São Paulo was carried out to identify patients who underwent invasive surgical procedures due to acute soccer-related facial fractures. Data points reviewed included gender, date of injury, type of fracture, date of surgery, and procedure performed. RESULTS: A total of 45 patients (31 from Escola Paulista de Medicina and 14 from Universidade de São Paulo) underwent surgical procedures to address facial fractures between March 2000 and September 2013. Forty-four patients were men, and mean age was 28 years. The fracture patterns seen were nasal bones (16 patients, 35%), orbitozygomatic (16 patients, 35%), mandibular (7 patients, 16%), orbital (6 patients, 13%), frontal (1 patient, 2%), and naso-orbito-ethmoid (1 patient, 2%). Mechanisms of injury included collisions with another player (n = 39) and being struck by the ball (n = 6). CONCLUSIONS: Although it is less common than orthopedic injuries, soccer players do sustain maxillofacial trauma. Knowledge of its frequency is important to first responders, nurses, and physicians who have initial contact with patients. Missed diagnosis or delayed treatment can lead to facial deformities and functional problems in the physiological actions of breathing, vision, and chewing.

3.
Am J Cardiol ; 103(4): 461-3, 2009 Feb 15.
Article in English | MEDLINE | ID: mdl-19195502

ABSTRACT

Recent data indicated that statin therapy may fail to reduce the incidence of coronary events in patients concomitantly using beta blockers. The aim of the present study was to examine whether the concomitant use of beta blockers would modify the anti-inflammatory action of statins. Changes in C-reactive protein (CRP) between days 1 and 5 after myocardial infarction were evaluated in 189 patients treated with simvastatin alone (S), beta blockers alone (B; propranolol or metoprolol), S + B, or neither of these 2 medications (N) in a prospective observational cohort. At baseline, median CRP was lower in the S group (0.40 mg/dl, interquartile range 0.1 to 0.6) than the other groups (B: 0.6 mg/dl, interquartile range 0.4 to 1.6; S + B: 0.5 mg/dl, interquartile range 0.3 to 1.2; and N: 0.6 mg/dl, interquartile range 0.2 to 1.5). By day 5, median CRP was 1.3 mg/dl (interquartile range 0.7 to 2.6), 4.3 (interquartile range 1.6 to 8.8), 4.6 (interquartile range 2.8 to 9.5), and 4.4 (interquartile range 1.9 to 9.9) for the S, B, S + B, and N groups, respectively. After adjusting for log(e) baseline CRP, the difference in log(e) CRP between days 1 and 5 was significantly lower in the S group compared with the B (-0.74 +/- 0.23 [SE], p = 0.001) or S + B group (-0.99 +/- 0.20 [SE], p <0.0001). The significance remained after adjustment for age, gender, and baseline CRP. There was no significant difference in change in CRP between the SB and B groups. In conclusion, the present study confirmed the anti-inflammatory action of statins and showed that concomitant use of beta blockers may significantly attenuate this effect.


Subject(s)
Adrenergic beta-Antagonists/pharmacology , C-Reactive Protein/analysis , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Myocardial Infarction/blood , Myocardial Infarction/drug therapy , Simvastatin/pharmacology , Adrenergic beta-Antagonists/therapeutic use , Aged , Cohort Studies , Drug Therapy, Combination , Female , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Male , Metoprolol/pharmacology , Metoprolol/therapeutic use , Middle Aged , Propranolol/pharmacology , Propranolol/therapeutic use , Simvastatin/therapeutic use , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL